
Psyched Wellness Provides Comprehensive Investor Update
Psyched Wellness Provides Comprehensive Investor Update

Psyched Wellness Provides Comprehensive Investor Update
Tilray Brands Reports Strong First Quarter Fiscal 2026 Results, Highlighting Continued Growth with Record Q1 Net Revenue of $210 Million and Net Income
Organigram Global Launches happly, a New U.S. Hemp-Derived THC Brand Offering Targeted Formulations for Three Mood States; Socialize, Relax, and Sleep
Canopy's DOJA facility now a medical cultivation site
Neural Portfolio Company Hanf.com Reports Strong Fiscal 2024 Results with 65% Revenue Growth, Positive Cash Flow and Double-Digit Operating Margin; Continued Growth in 2025; First Half Revenues Up 31% Year-Over-Year
Canopy Growth Announces DOJA as Dedicated Canadian Medical Facility
Canopy Growth's Canopy USA, JP Brands enter partnership
Cannara Biotech approved for DTC electronic clearing
JP Brand Advisors and Canopy USA Form Strategic Partnership to Expand Hemp Beverage Distribution
Cannara Announces DTC Eligibility to Facilitate U.S. Investor Access and Strengthens Balance Sheet through completion of Debt-to-Equity Conversion
Pharmacielo closes sale of La Margarita property
Optimi psilocybin capsules included in Medibank program
PharmaCielo Completes La Margarita Land Sale, Repays Banco Agrario Loan, Strengthens Balance Sheet, Completes Audit
Delivra Health Brands Reports Continued Revenue Growth and Positive Adjusted EBITDA(1) in FY2025
Optimi Health's Psilocybin Capsules Selected for Medibank Insurance Program